Circulating tumor DNA in head and neck cancer: Early successes and future promise

Joanne Soo; Michael C Jin; Beth M Beadle; F Christopher Holsinger; Andrey Finegersh

doi:10.1002/cncr.34189

Circulating tumor DNA in head and neck cancer: Early successes and future promise

Cancer. 2022 Jun 1;128(11):2061-2063. doi: 10.1002/cncr.34189. Epub 2022 Mar 17.

Authors

Joanne Soo¹, Michael C Jin¹, Beth M Beadle², F Christopher Holsinger¹, Andrey Finegersh¹

Affiliations

¹ Division of Head and Neck Surgery, Department of Otolaryngology, Stanford University School of Medicine, Palo Alto, California.
² Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.

PMID: 35298053
DOI: 10.1002/cncr.34189

Abstract

The genetic components (DNA) of human papillomavirus-related throat cancer (in the oropharynx) might be measured after surgery to help to predict whether treatment has been successful.

Keywords: HPV; TORS; circulating tumor DNA; digital droplet PCR; liquid biopsy; oropharyngeal cancer.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Circulating Tumor DNA* / genetics
DNA, Viral / genetics
Head and Neck Neoplasms* / genetics
Humans
Oropharyngeal Neoplasms* / pathology
Papillomaviridae / genetics
Papillomavirus Infections* / complications
Papillomavirus Infections* / genetics
Papillomavirus Infections* / pathology

Substances

Circulating Tumor DNA
DNA, Viral